Evoq Remedies Limited (BOM:543500)
3.150
0.00 (0.00%)
At close: Feb 13, 2026
Evoq Remedies Revenue
Evoq Remedies had revenue of 265.68M INR in the half year ending September 30, 2025, with 580.78% growth. This brings the company's revenue in the last twelve months to 407.29M, up 1,585.10% year-over-year. In the fiscal year ending March 31, 2025, Evoq Remedies had annual revenue of 141.71M with 124.62% growth.
Revenue (ttm)
407.29M
Revenue Growth
+1,585.10%
P/S Ratio
0.19
Revenue / Employee
n/a
Employees
n/a
Market Cap
78.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 141.71M | 78.62M | 124.62% |
| Mar 31, 2024 | 63.09M | -201.04M | -76.11% |
| Mar 31, 2023 | 264.13M | 96.29M | 57.38% |
| Mar 31, 2022 | 167.83M | 67.58M | 67.42% |
| Mar 31, 2021 | 100.25M | 9.53M | 10.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Checkpoint Trends | 2.95B |
| Dipna Pharmachem | 1.07B |
| Medico Intercontinental | 822.95M |
| Medistep Healthcare | 496.55M |
| Chandra Bhagat Pharma | 493.95M |
| Zenlabs Ethica | 493.24M |
| Muller & Phipps (India) | 72.38M |
| Pentokey Organy (India) | 45.60M |